Skip to main content
Trades ▾
Trading Strategies
Market Analysis
News
Tactics ▾
Fundamental
Options
Volatility
Dividends
Spin-Offs
COT
Education
Data ▾
Market Data
Interactive Charts
Sectors ▾
Commodities
Forex
Interest Rates
Energy
Crypto
Agriculture
Index
Equities
ETFs
FINtech
Alternative Data
Hedge Funds
Magazine ▾
Most Popular
Trader Questions
Trader Lists
Magazine Archives
About
Subscribe
Log in
Facebook
Twitter
Linkedin
Moderntrader
Mobile User menu
Subscribe
Log in
Main menu
Trades ▾
Trading Strategies
Market Analysis
News
Tactics ▾
Fundamental
Options
Volatility
Dividends
Spin-Offs
COT
Education
Data ▾
Market Data
Interactive Charts
Sectors ▾
Commodities
Forex
Interest Rates
Energy
Crypto
Agriculture
Index
Equities
ETFs
FINtech
Alternative Data
Hedge Funds
Magazine ▾
Most Popular
Trader Questions
Trader Lists
Magazine Archives
About
User menu
Subscribe
Log in
Search form
Search
Search
Caroline Humer, Reuters
Valeant says Goldman Sachs sold 1.3 million shares backing loan to CEO
Caroline Humer, Reuters
November 6, 2015
Valeant Pharmaceuticals International said on Friday that Goldman Sachs sold 1.3 million shares of Valeant on Nov. 5 that were securing loans made to its CEO Michael Pearson.
